Biogen Idec | search
Click here to view Biogen Idec news from 60+ newspapers.
Bookmark or Share- Home | BiogenBiogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
- Biogen IDEC - Home - Home - Idec PharmaPaul Chinn leads a Biogen Idec team in groundbreaking cancer research. Read how Paul’s work has helped Rick. Eastern Cooperative Oncology Group (ECOG) Phase III Trial Of Rituxan Maintenance Therapy In Indolent Non-Hodgkin’s Lymphoma Reaches Pre-Specified Efficacy Endpoint Early. Careers. Biogen Idec invests in its employees.
- FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to ...In the U.S., Biogen Idec will offer a variety of personalized assistance and resources through MyELOCTATE ™ Services. As part of the company’s global commitment to the hemophilia community, Biogen Idec will provide equitable access to therapy including humanitarian donations.
- Biogen - WikipediaBiogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...
- Biogen Idec - AnnualReports.comBiogen Idec creates new standards of care in oncology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare.
More
